There is no difference in the rate of death from any cause at 10 years for patients undergoing CABG with bilateral or single internal-thoracic-artery grafting.
The combination of rivaroxaban 2.5 mg twice daily plus aspirin was associated with similar reductions in major adverse cardiovascular events as observed in the larger COMPASS trial.
Stroke risk remained significantly lower after PCI than after CABG at 5-year follow-up.
There was a decrease in observed and expected mortality rates as well as risk factor rates from 2002 to 2014 in Massachusetts.
Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.
Coronary-artery bypass grafting patients were found to live longer if their surgeons performed the operation with cardiopulmonary bypass.
